% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Jahn:305743,
author = {A. Jahn$^*$ and C. Heining$^*$ and S. Fröhling$^*$ and H.
Glimm$^*$ and E. Schröck$^*$},
title = {{T}argeted therapy in patients with genetic tumor
syndromes.},
journal = {Medizinische Genetik},
volume = {37},
number = {4},
issn = {0936-5931},
address = {Berlin},
publisher = {de Gruyter},
reportid = {DKFZ-2025-02366},
pages = {321 - 335},
year = {2025},
abstract = {Significant progress in comprehensive molecular diagnostics
and targeted therapies for advanced malignancies has, in
part, led to substantial improvements in patient outcomes.
Nevertheless, comprehensive genomic profiling necessitates
interdisciplinary discussion of potential clinical
recommendations within interdisciplinary molecular tumor
boards. (Likely) pathogenic germline variants (PGVs)
typically warrant genetic counseling for patients and, where
appropriate, their relatives. Concurrently, the rapidly
expanding availability of targeted therapies introduces new
therapeutic implications based on germline alterations that
must be integrated into clinical decision-making. Moreover,
the identification of PGVs may not only inform therapy in
patients with manifest malignancy but also offer
opportunities for targeted chemoprevention.},
keywords = {Precision oncology (Other) / biomarker-targeted therapy
(Other) / clinical trials (Other) / genetic testing and
prevention (Other) / genetic tumor syndrome (Other)},
cin = {DD01 / B340},
ddc = {610},
cid = {I:(DE-He78)DD01-20160331 / I:(DE-He78)B340-20160331},
pnm = {312 - Funktionelle und strukturelle Genomforschung
(POF4-312)},
pid = {G:(DE-HGF)POF4-312},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:41210226},
pmc = {pmc:PMC12594532},
doi = {10.1515/medgen-2025-2045},
url = {https://inrepo02.dkfz.de/record/305743},
}